Literature DB >> 19478300

Age at onset of first episode and time to treatment in in-patients with bipolar disorder.

Gunnar Morken1, Arne E Vaaler, Gunn E Folden, Ole A Andreassen, Ulrik F Malt.   

Abstract

This study aimed to investigate the relationship between age at onset and time to first pharmacological treatment in patients with either bipolar I or II disorder. A total of 146 consecutive in-patients acutely admitted from the same catchment area were included. Patients were divided into four age groups: 0-12 years (23%); 13-18 years (32%); 19-29 years (26%); and > or =30 years (18%). Mean age at first affective episode was 20.2 years (s.d.=11.8). This represents a similar pattern to the age at onset seen in out-patients in the USA. Early age at onset predicted a longer time to first pharmacological treatment (rho =-0.695, P<0.01).

Entities:  

Mesh:

Year:  2009        PMID: 19478300     DOI: 10.1192/bjp.bp.108.054452

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  11 in total

1.  Excessive cannabis use is associated with earlier age at onset in bipolar disorder.

Authors:  Trine V Lagerberg; Kjetil Sundet; Sofie R Aminoff; Akiah O Berg; Petter A Ringen; Ole A Andreassen; Ingrid Melle
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-01-26       Impact factor: 5.270

2.  Duration of untreated bipolar disorder: a multicenter study.

Authors:  Ling Zhang; Xin Yu; Yi-Ru Fang; Gabor S Ungvari; Chee H Ng; Helen F K Chiu; Hui-Chun Li; Hai-Chen Yang; Qing-Rong Tan; Xiu-Feng Xu; Gang Wang; Yu-Tao Xiang
Journal:  Sci Rep       Date:  2017-03-22       Impact factor: 4.379

3.  Clinical characteristics of patients with bipolar disorder and premorbid traumatic brain injury: a cross-sectional study.

Authors:  Ole Kristian Drange; Arne Einar Vaaler; Gunnar Morken; Ole Andreas Andreassen; Ulrik Fredrik Malt; Per Ivar Finseth
Journal:  Int J Bipolar Disord       Date:  2018-09-10

4.  Exploring factors of diagnostic delay for patients with bipolar disorder: a population-based cohort study.

Authors:  Ágnes Lublóy; Judit Lilla Keresztúri; Attila Németh; Péter Mihalicza
Journal:  BMC Psychiatry       Date:  2020-02-19       Impact factor: 3.630

5.  Neurocognitive profiles in treatment-resistant bipolar I and bipolar II disorder depression.

Authors:  Ute Kessler; Helle K Schoeyen; Ole A Andreassen; Geir E Eide; Åsa Hammar; Ulrik F Malt; Ketil J Oedegaard; Gunnar Morken; Kjetil Sundet; Arne E Vaaler
Journal:  BMC Psychiatry       Date:  2013-04-04       Impact factor: 3.630

6.  Cognitive behavioral therapy for insomnia in euthymic bipolar disorder: study protocol for a randomized controlled trial.

Authors:  Mette Kvisten Steinan; Karoline Krane-Gartiser; Knut Langsrud; Trond Sand; Håvard Kallestad; Gunnar Morken
Journal:  Trials       Date:  2014-01-16       Impact factor: 2.279

7.  Early specific cognitive-behavioural psychotherapy in subjects at high risk for bipolar disorders: study protocol for a randomised controlled trial.

Authors:  Andrea Pfennig; Karolina Leopold; Andreas Bechdolf; Christoph U Correll; Martin Holtmann; Martin Lambert; Carolin Marx; Thomas D Meyer; Steffi Pfeiffer; Andreas Reif; Maren Rottmann-Wolf; Natalie M Schmitt; Thomas Stamm; Georg Juckel; Michael Bauer
Journal:  Trials       Date:  2014-05-08       Impact factor: 2.279

8.  Risk factors of cycle acceleration in acutely admitted patients with bipolar disorder.

Authors:  P I Finseth; G Morken; U F Malt; O A Andreassen; A E Vaaler
Journal:  Acta Psychiatr Scand       Date:  2014-06-24       Impact factor: 6.392

9.  Sleep problems in bipolar disorders: more than just insomnia.

Authors:  M K Steinan; J Scott; T V Lagerberg; I Melle; O A Andreassen; A E Vaaler; G Morken
Journal:  Acta Psychiatr Scand       Date:  2015-11-21       Impact factor: 6.392

Review 10.  Right-sided brain lesions predominate among patients with lesional mania: evidence from a systematic review and pooled lesion analysis.

Authors:  J Bernardo Barahona-Corrêa; Gonçalo Cotovio; Rui M Costa; Ricardo Ribeiro; Ana Velosa; Vera Cruz E Silva; Christoph Sperber; Hans-Otto Karnath; Suhan Senova; Albino J Oliveira-Maia
Journal:  Transl Psychiatry       Date:  2020-05-12       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.